Emcure Pharmaceuticals has received approval for the incorporation of a wholly-owned subsidiary (WOS) by the name ‘Emcutix Biopharmaceuticals’ in Pune, Maharashtra, India. WoS is being incorporated to manufacture, promote, sale and distribute pharmaceuticals and other related product(s). A Committee of the Board of Directors of the Company in their meeting held on September 13, 2024, has inter-alia approved the same.
Emcure Pharmaceuticals is one of the leading Indian pharmaceutical companies engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1863.45 |
| Dr. Reddys Lab | 1291.05 |
| Cipla | 1415.30 |
| Zydus Lifesciences | 1084.35 |
| Lupin | 2339.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: